Beta
Login / Sign Up
Latest News
Earnings
Earning Calendar
Analyst Rating
Pricing
Novo Nordisk (NVO): CFRA downgrades to Sell, PT at $38
NVO
Novo Nordisk
•
CFRA
•
Sep 22, 2026
1
Share